These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7019402)
1. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. White NH; Waltman SR; Krupin T; Santiago JV J Pediatr; 1981 Jul; 99(1):41-5. PubMed ID: 7019402 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Kitabchi AE; Fisher JN; Burghen GA; Gaylord MS; Blank NM Diabetes Care; 1979; 2(5):421-4. PubMed ID: 510142 [TBL] [Abstract][Full Text] [Related]
3. Improved control in diabetes with continuous subcutaneous insulin infusion. Schiffrin A; Colle E; Belmonte M Diabetes Care; 1980; 3(6):643-9. PubMed ID: 7004811 [TBL] [Abstract][Full Text] [Related]
4. [Refractory diabetes mellitus]. Goto Y; Sato S; Chiba M; Kuriki A Naika; 1971 Jun; 27(6):1301-6. PubMed ID: 4997126 [No Abstract] [Full Text] [Related]
5. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of angio- and neuropathies in patients with diabetes mellitus]. Draznin NM Sov Med; 1973 Dec; 36(12):17-21. PubMed ID: 4779359 [No Abstract] [Full Text] [Related]
8. Vitreous fluorophotometry in adult-onset diabetes mellitus. Waltman SR; Krupin T; Kilo C; Becker B Am J Ophthalmol; 1979 Sep; 88(3 Pt 1):342-5. PubMed ID: 484662 [TBL] [Abstract][Full Text] [Related]
9. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416 [TBL] [Abstract][Full Text] [Related]
11. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Pietri A; Ehle AL; Raskin P Diabetes; 1980 Aug; 29(8):668-71. PubMed ID: 7002680 [TBL] [Abstract][Full Text] [Related]
12. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Slama G; Hautecouverture M; Assan R; Tchobroutsky G Diabetes; 1974 Sep; 23(9):732-8. PubMed ID: 4414927 [No Abstract] [Full Text] [Related]
13. Resolution of diabetic autonomic neuropathy. Burden ML; Burden AC Postgrad Med J; 2002 Jun; 78(920):360-1. PubMed ID: 12151692 [TBL] [Abstract][Full Text] [Related]
14. Control of insulin-dependent diabetes with portable miniaturized infusion systems. Hepp KD; Renner R; Piwernetz K; Mehnert H Diabetes Care; 1980; 3(2):309-13. PubMed ID: 6993145 [TBL] [Abstract][Full Text] [Related]
15. Relationship among esophageal dysfunction, diabetic gastroenteropathy, and peripheral neuropathy. Russell CO; Gannan R; Coatsworth J; Neilsen R; Allen F; Hill LD; Pope CE Dig Dis Sci; 1983 Apr; 28(4):289-93. PubMed ID: 6831992 [TBL] [Abstract][Full Text] [Related]
16. The importance of intensive supervision in determining the efficacy of insulin pump therapy. Nathan DM Diabetes Care; 1983; 6(3):295-7. PubMed ID: 6347582 [TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus. Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412 [TBL] [Abstract][Full Text] [Related]